Loading: 100%
MANNKIND CORP logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 153 (as per Q1 2017)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker MNKDno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 170,01,53,04,56,0
datesClosing price (adj.)
13.10.20175.28
11.10.20175.47
04.10.20173.54
27.09.20171.85
20.09.20171.98
13.09.20172.22
06.09.20171.97
30.08.20171.89
23.08.20171.43
16.08.20171.43
09.08.20171.15
02.08.20171.19
26.07.20171.32
19.07.20171.38
12.07.20171.17
05.07.20171.24
27.06.20171.56
20.06.20171.53
13.06.20171.43
06.06.20171.57
30.05.20171.65
23.05.20171.30
16.05.20171.22
09.05.20171.12
02.05.20170.80
25.04.20170.90
18.04.20171.22
11.04.20171.38
04.04.20171.40
28.03.20171.63
21.03.20172.07
14.03.20172.02
07.03.20171.97
28.02.20172.65
21.02.20172.55
14.02.20172.72
07.02.20172.57
31.01.20173.52
24.01.20173.35
17.01.20173.40
10.01.20173.21
03.01.20173.16
27.12.20163.40
19.12.20163.93
12.12.20163.06
05.12.20162.91
28.11.20162.66
21.11.20163.05
14.11.20163.25
07.11.20162.20
31.10.20162.09
24.10.20162.76
17.10.20162.34
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
5.28n/a
Market Capitalisation
in million USD
506n/a
Enterprise Value
in million USD
652n/a
Common Shares Outstanding
as per Mar 31, 2017
95,776,297n/a
Preferred Shares Outstanding
as per Mar 31, 2017
n/a
Average Basic Shares Outstanding
TTM
92,053,000n/a
Average Diluted Shares Outstanding
TTM
94,578,250n/a
Index Membership
n/a
Business Summary
MannKind Corp is a development stage biotech firm. It is engaged in the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and cancer.
no data available
Key Financials & Ratios (all figures TTM as per Mar 31, 2017, million USD, full statements further below)
Profit & Loss
Revenues 178n/a
Gross Profit 130n/a
Operating Income 62n/a
EBITDA 0n/a
Net Profit 134n/a
Balance Sheet
Cash and Cash Equivalents 48n/a
Receivables 0n/a
Total Current Assets 56n/a
PP&E 28n/a
Total Assets 85n/a
Accounts Payable 2n/a
Current Debt 72n/a
Total Current Liabilities 93n/a
Long-Term Debt 123n/a
Total Liabilities 284n/a
Total Equity -199n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 73.3%n/a
Operating Margin 35.1%n/a
Net Profit Margin 75.5%n/a
Return on Equity -67.5%n/a
Return on Assets 157.5%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS 1.42n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales 3.67n/a
Book to Market Value -0.39n/a
Other Ratios
Current Ratio 60.3%n/a
Liabilities to Equity Ratio -142.9%n/a
Debt to Assets Ratio 228.3%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
0
0
0
0
0
0
0
175
Sales & Services Revenue
0
0
0
0
0
0
0
175
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
0
0
0
0
0
0
-65
-50
Cost of Goods & Services
0
0
0
0
0
0
-65
-50
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
-65
125
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-210
-153
-141
-147
-169
-180
-71
-62
Selling, General & Administrative
-53
-40
-41
-45
-60
-79
-41
-47
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
-156
-112
-100
-102
-110
-100
-30
-15
Depreciation & Amortization
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
Operating Income (Loss)
-210
-152
-141
-147
-169
-180
-135
63
Non-Operating Income (Loss)
-5
-8
-9
-12
-16
-16
-20
-16
Interest Expense, net
-5
-7
-11
-11
-15
-18
-21
-15
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
-1
2
-1
-1
2
1
-1
Pretax Income (Loss), Adjusted
-214
-160
-150
-159
-185
-195
-155
47
Abnormal Gains (Losses)
-6
-10
-11
-10
-6
-3
-213
79
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
-220
-171
-161
-170
-191
-198
-368
126
Income Tax (Expense) Benefit, net
0
0
0
0
0
0
0
0
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-220
-171
-161
-169
-191
-198
-368
126
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-220
-171
-161
-169
-191
-198
-368
126
Minority Interest
0
0
0
0
0
0
0
0
Net Income
-220
-171
-161
-169
-191
-198
-368
126
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-220
-171
-161
-169
-191
-198
-368
126
Remarks
restated on Mar 15, 2012 n/a
calculated values,
restated on Mar 18, 2013 n/a
calculated values,
restated on Mar 3, 2014 n/a
calculated values,
restated on Mar 2, 2015 n/a
calculated values,
restated on Mar 15, 2016 n/a
calculated values,
restated on Mar 16, 2017 n/a
calculated values,
restated on Mar 16, 2017 n/a
calculated values,
restated on Mar 16, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
70
3
62
71
121
59
23
Cash & Cash Equivalents
n/a
66
3
62
71
121
59
23
Short Term Investments
n/a
4
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
1
0
0
0
50
0
31
Accounts Receivable, Net
n/a
1
0
0
0
50
0
31
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
0
0
0
0
10
0
2
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
3
3
5
5
20
18
21
Prepaid Expenses
n/a
3
3
5
5
20
4
4
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
17
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
14
0
Total Current Assets
n/a
74
6
67
76
201
77
77
Property, Plant & Equipment, Net
n/a
202
193
184
177
192
49
29
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
1
1
1
6
1
1
1
Intangible Assets
n/a
0
0
0
0
0
0
0
Goodwill
n/a
0
0
0
0
0
0
0
Other Intangible Assets
n/a
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
1
1
1
6
1
1
1
Total Noncurrent Assets
n/a
203
194
185
182
193
50
30
Total Assets
n/a
277
200
251
259
394
126
107
Liabilities and owners' equity
Payables & Accruals
n/a
18 18134000
25 25360000
30 30332000
25 25494000
34 33600000
24 23528000
11 11200000
Accounts Payable
n/a
3 3294000
5 4624000
5 4555000
4 3860000
7 7394000
16 15599000
3 3263000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
15 14840000
21 20736000
26 25777000
22 21634000
26 26206000
8 7929000
8 7937000
Short Term Debt
n/a
0 0
0 0
114 114443000
102 102300000
172 172350000
75 74582000
71 71339000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
197 197403000
170 170209000
10 9512000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
197 196967000
0 0
3 3419000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 436000
170 170209000
6 6093000
Total Current Liabilities
n/a
18 18134000
25 25360000
145 144775000
128 127794000
403 403353000
268 268319000
92 92051000
Long Term Debt
n/a
209 209335000
211 210642000
98 97583000
98 98439000
0 0
81 81305000
124 123577000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
-1,539 -1539423000
-1,658 -1658343000
-1,985 -1985277000
63 63126000
65 64856000
127 127117000
75 75028000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
7 7381000
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
-1,539 -1539423000
-1,658 -1658343000
-1,985 -1985277000
63 63126000
65 64856000
127 127117000
68 67647000
Total Noncurrent Liabilities
n/a
-1,330 -1330088000
-1,448 -1447701000
-1,888 -1887694000
162 161565000
65 64856000
208 208422000
199 198605000
Total Liabilities
n/a
-1,312 -1311954000
-1,422 -1422341000
-1,743 -1742919000
289 289359000
468 468209000
477 476741000
291 290656000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
1,589 1589136000
1,622 1621850000
1,994 1994239000
2,266 2265693000
2,421 2421028000
2,513 2512920000
2,554 2553996000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
0 0
0 0
0 0
-2,296 -2296402000
-2,495 -2494784000
-2,863 -2863229000
-2,738 -2737565000
Other Equity
n/a
0 74000
0 44000
0 -6000
0 -4000
0 -14000
0 -20000
0 -24000
Equity Before Minority Interest
n/a
1,589 1589210000
1,622 1621894000
1,994 1994233000
-31 -30713000
-74 -73770000
-350 -350329000
-184 -183593000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
1,589 1589210000
1,622 1621894000
1,994 1994233000
-31 -30713000
-74 -73770000
-350 -350329000
-184 -183593000
Total Liabilities & Equity
n/a
277 277256000
200 199553000
251 251314000
259 258646000
394 394439000
126 126412000
107 107063000
Remarks restated on n/a restated on Mar 15, 2012 n/a restated on Mar 18, 2013 n/a restated on Mar 3, 2014 n/a restated on Mar 2, 2015 n/a restated on Mar 15, 2016 n/a restated on Mar 16, 2017 n/a restated on May 10, 2017 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
-220
-171
-161
-169
-191
-198
-368
126
Net Income
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Depreciation & Amortization
19
17
16
14
14
19
13
4
Non-Cash Items
34
15
12
14
46
53
260
-69
Stock-Based Compensation
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
Change in Working Capital
-4
-3
3
6
-1
-72
33
-32
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
Cash from Operating Activities
-172
-141
-130
-135
-132
-199
-63
29
Change in Fixed Assets & Intangibles
-19
-10
-7
-1
-8
-24
-10
-1
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
16
-2
4
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
0
0
44
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
Cash from Investing Activities
-3
-12
-3
-1
-8
-24
-10
43
Dividends Paid
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
135
183
53
13
214
85
-58
42
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
62
17
11
168
4
12
4
1
Increase in Capital Stock
62
17
11
168
4
12
4
1
Decrease in Capital Stock
0
0
0
0
0
0
0
0
Other Financing Activities
-7
-3
-1
-1
-5
-27
-3
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
Cash from Financing Activities
190
196
63
180
212
70
-57
43
Net Cash Before Disc. Operations and FX
15
44
-69
44
71
-153
-130
115
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
Net Cash Before FX
15
44
-69
44
71
-153
-130
115
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
Net Changes in Cash
15
44
-69
44
71
-153
-130
115
Remarks
restated on Mar 15, 2012 n/a
calculated values,
restated on Mar 18, 2013 n/a
calculated values,
restated on Mar 3, 2014 n/a
calculated values,
restated on Mar 2, 2015 n/a
calculated values,
restated on Mar 15, 2016 n/a
calculated values,
restated on Mar 16, 2017 n/a
calculated values,
restated on Mar 16, 2017 n/a
calculated values,
restated on Mar 16, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo